GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSRNOG00000005343 | estrogen receptor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Esr2 | rn6_v1_chr6_-_99214251_99214251 | -0.54 | 1.1e-25 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_28066635 | 34.22 |
ENSRNOT00000005844
|
Pah
|
phenylalanine hydroxylase |
chr20_-_12820466 | 33.76 |
ENSRNOT00000001699
|
Ftcd
|
formimidoyltransferase cyclodeaminase |
chr20_-_9876008 | 32.53 |
ENSRNOT00000001537
|
Tff2
|
trefoil factor 2 |
chr10_-_62273119 | 31.91 |
ENSRNOT00000004322
|
Serpinf2
|
serpin family F member 2 |
chr8_-_50531423 | 30.71 |
ENSRNOT00000090985
ENSRNOT00000074942 |
Apoc3
|
apolipoprotein C3 |
chr20_-_14193690 | 28.89 |
ENSRNOT00000058237
|
Upb1
|
beta-ureidopropionase 1 |
chr10_-_77512032 | 28.59 |
ENSRNOT00000003295
|
Pctp
|
phosphatidylcholine transfer protein |
chr3_-_55587946 | 27.67 |
ENSRNOT00000075107
|
Abcb11
|
ATP binding cassette subfamily B member 11 |
chr6_-_138093643 | 27.54 |
ENSRNOT00000045874
|
Igh-6
|
immunoglobulin heavy chain 6 |
chr15_+_18710492 | 27.51 |
ENSRNOT00000012532
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr1_+_72636959 | 26.95 |
ENSRNOT00000023489
|
Il11
|
interleukin 11 |
chr15_-_45550285 | 26.90 |
ENSRNOT00000012948
|
Gucy1b2
|
guanylate cyclase 1 soluble subunit beta 2 |
chr2_-_23289266 | 26.41 |
ENSRNOT00000061708
|
Bhmt2
|
betaine-homocysteine S-methyltransferase 2 |
chr8_+_116857684 | 25.96 |
ENSRNOT00000026711
|
Mst1
|
macrophage stimulating 1 |
chr8_-_50539331 | 25.63 |
ENSRNOT00000088997
|
AABR07073400.1
|
|
chr8_+_50537009 | 25.06 |
ENSRNOT00000080658
|
Apoa4
|
apolipoprotein A4 |
chr1_-_189238776 | 24.86 |
ENSRNOT00000020817
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr6_-_7058314 | 24.80 |
ENSRNOT00000045996
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr20_+_4087618 | 24.59 |
ENSRNOT00000000522
ENSRNOT00000060327 ENSRNOT00000080590 |
RT1-Db1
|
RT1 class II, locus Db1 |
chr6_-_138249382 | 24.52 |
ENSRNOT00000085678
ENSRNOT00000006912 |
Ighm
|
immunoglobulin heavy constant mu |
chr18_+_56071478 | 24.37 |
ENSRNOT00000025344
ENSRNOT00000025354 |
Cd74
|
CD74 molecule |
chr4_-_70747226 | 24.30 |
ENSRNOT00000044960
|
LOC102554637
|
anionic trypsin-2-like |
chr1_+_250426158 | 24.22 |
ENSRNOT00000067643
|
A1cf
|
APOBEC1 complementation factor |
chr20_-_5805627 | 23.80 |
ENSRNOT00000085996
|
Clps
|
colipase |
chr1_+_100131449 | 23.73 |
ENSRNOT00000091964
ENSRNOT00000071416 |
Klk1
|
kallikrein 1 |
chr3_-_2727616 | 23.44 |
ENSRNOT00000061904
|
C8g
|
complement C8 gamma chain |
chr10_+_14240219 | 22.48 |
ENSRNOT00000020233
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr15_-_3650819 | 21.96 |
ENSRNOT00000014273
|
Plau
|
plasminogen activator, urokinase |
chr20_-_5806097 | 21.03 |
ENSRNOT00000000611
|
Clps
|
colipase |
chr3_+_171213936 | 21.02 |
ENSRNOT00000031586
|
Pck1
|
phosphoenolpyruvate carboxykinase 1 |
chr8_+_85553734 | 20.98 |
ENSRNOT00000044944
|
Gsta5
|
glutathione S-transferase alpha 5 |
chr9_+_95501778 | 20.62 |
ENSRNOT00000086805
|
Spp2
|
secreted phosphoprotein 2 |
chr8_+_116708027 | 20.47 |
ENSRNOT00000047309
|
Actl11
|
actin-like 11 |
chr8_+_55603968 | 20.44 |
ENSRNOT00000066848
|
Pou2af1
|
POU class 2 associating factor 1 |
chr17_+_76002275 | 20.39 |
ENSRNOT00000092665
ENSRNOT00000086701 |
Echdc3
|
enoyl CoA hydratase domain containing 3 |
chr16_-_81834945 | 20.38 |
ENSRNOT00000037806
|
F7
|
coagulation factor VII |
chr7_-_70452675 | 20.15 |
ENSRNOT00000090498
|
AC114111.1
|
|
chr18_+_70733872 | 20.05 |
ENSRNOT00000067018
|
Acaa2
|
acetyl-CoA acyltransferase 2 |
chr2_-_195678848 | 20.03 |
ENSRNOT00000028303
ENSRNOT00000075569 |
Oaz3
|
ornithine decarboxylase antizyme 3 |
chr10_+_89285855 | 19.92 |
ENSRNOT00000028033
|
G6pc
|
glucose-6-phosphatase, catalytic subunit |
chr1_+_219144205 | 19.63 |
ENSRNOT00000083942
|
Unc93b1
|
unc-93 homolog B1 (C. elegans) |
chr4_+_153921115 | 19.34 |
ENSRNOT00000018821
|
Slc6a12
|
solute carrier family 6 member 12 |
chr12_+_10636275 | 19.29 |
ENSRNOT00000001285
|
Cyp3a18
|
cytochrome P450, family 3, subfamily a, polypeptide 18 |
chr10_+_89286047 | 19.25 |
ENSRNOT00000085831
|
G6pc
|
glucose-6-phosphatase, catalytic subunit |
chr16_+_6970342 | 19.21 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr7_-_15190796 | 19.02 |
ENSRNOT00000006533
|
Cyp4f1
|
cytochrome P450, family 4, subfamily f, polypeptide 1 |
chr1_+_189364288 | 18.96 |
ENSRNOT00000080338
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr6_-_129010271 | 18.80 |
ENSRNOT00000075378
|
Serpina10
|
serpin family A member 10 |
chr1_-_89539210 | 18.71 |
ENSRNOT00000077462
ENSRNOT00000028644 |
Hpn
|
hepsin |
chr19_+_15094309 | 18.58 |
ENSRNOT00000083500
|
Ces1f
|
carboxylesterase 1F |
chr20_+_28989491 | 18.53 |
ENSRNOT00000074524
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr1_+_282694906 | 18.32 |
ENSRNOT00000074303
|
Ces2c
|
carboxylesterase 2C |
chr8_+_50559126 | 18.16 |
ENSRNOT00000024918
|
Apoa5
|
apolipoprotein A5 |
chr8_-_85645718 | 17.87 |
ENSRNOT00000032185
|
Gsta2
|
glutathione S-transferase alpha 2 |
chr2_-_88135410 | 17.81 |
ENSRNOT00000014180
|
Car3
|
carbonic anhydrase 3 |
chr11_+_65022100 | 17.68 |
ENSRNOT00000003934
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr16_+_74865516 | 17.63 |
ENSRNOT00000058072
|
Atp7b
|
ATPase copper transporting beta |
chr12_-_22194287 | 17.63 |
ENSRNOT00000082895
ENSRNOT00000001905 |
Tfr2
|
transferrin receptor 2 |
chr1_+_197839430 | 17.23 |
ENSRNOT00000025043
|
Rabep2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr5_-_160383782 | 17.17 |
ENSRNOT00000018349
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr10_+_57239993 | 17.12 |
ENSRNOT00000067919
|
LOC687707
|
hypothetical protein LOC687707 |
chr8_-_50526843 | 17.07 |
ENSRNOT00000092188
|
AABR07070085.1
|
|
chr5_+_60528997 | 17.02 |
ENSRNOT00000051445
|
Grhpr
|
glyoxylate and hydroxypyruvate reductase |
chr1_+_282568287 | 16.96 |
ENSRNOT00000015997
|
Ces2i
|
carboxylesterase 2I |
chr8_-_23148396 | 16.94 |
ENSRNOT00000075237
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr18_-_24929091 | 16.91 |
ENSRNOT00000019596
|
Proc
|
protein C |
chr9_-_4876023 | 16.90 |
ENSRNOT00000065839
|
RGD1559960
|
similar to Sulfotransferase K1 (rSULT1C2) |
chr4_+_99063181 | 16.89 |
ENSRNOT00000008840
|
Fabp1
|
fatty acid binding protein 1 |
chr13_-_102721218 | 16.80 |
ENSRNOT00000005459
|
Marc1
|
mitochondrial amidoxime reducing component 1 |
chr16_-_32868680 | 16.72 |
ENSRNOT00000015974
ENSRNOT00000082392 |
Aadat
|
aminoadipate aminotransferase |
chr10_+_109708755 | 16.65 |
ENSRNOT00000083601
|
Gcgr
|
glucagon receptor |
chr10_-_65692016 | 16.61 |
ENSRNOT00000085074
ENSRNOT00000038690 |
Slc13a2
|
solute carrier family 13 member 2 |
chr9_+_100285804 | 16.58 |
ENSRNOT00000079305
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr1_-_85317968 | 16.33 |
ENSRNOT00000026891
|
Gmfg
|
glia maturation factor, gamma |
chr9_+_4817854 | 16.28 |
ENSRNOT00000040879
|
LOC100910526
|
sulfotransferase 1C2-like |
chr3_+_16846412 | 16.21 |
ENSRNOT00000074266
|
AABR07051551.1
|
|
chr1_+_189241593 | 16.12 |
ENSRNOT00000046025
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr14_-_80973456 | 16.10 |
ENSRNOT00000013257
|
Hgfac
|
HGF activator |
chr12_+_9446940 | 16.03 |
ENSRNOT00000074791
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase |
chr14_-_19072677 | 15.94 |
ENSRNOT00000060548
|
LOC360919
|
similar to alpha-fetoprotein |
chr3_-_80543031 | 15.76 |
ENSRNOT00000022233
|
F2
|
coagulation factor II |
chr2_-_23256158 | 15.71 |
ENSRNOT00000015336
|
Bhmt
|
betaine-homocysteine S-methyltransferase |
chr5_-_77408323 | 15.69 |
ENSRNOT00000046857
ENSRNOT00000046760 |
LOC259245
Mup4
|
alpha-2u globulin PGCL5 major urinary protein 4 |
chr5_-_134207847 | 15.67 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr20_+_5351605 | 15.66 |
ENSRNOT00000089306
ENSRNOT00000041590 ENSRNOT00000081240 ENSRNOT00000082538 |
RT1-A1
|
RT1 class Ia, locus A1 |
chr19_-_43911057 | 15.66 |
ENSRNOT00000026017
|
Ctrb1
|
chymotrypsinogen B1 |
chr1_-_73619356 | 15.62 |
ENSRNOT00000074352
|
Lilrb3
|
leukocyte immunoglobulin like receptor B3 |
chr4_+_149261044 | 15.58 |
ENSRNOT00000066670
|
Cxcl12
|
C-X-C motif chemokine ligand 12 |
chr7_-_12635943 | 15.58 |
ENSRNOT00000015029
|
Cfd
|
complement factor D |
chr3_-_16999720 | 15.50 |
ENSRNOT00000074382
|
RGD1563231
|
similar to immunoglobulin kappa-chain VK-1 |
chr1_-_169005190 | 15.49 |
ENSRNOT00000043719
|
Hbe1
|
hemoglobin subunit epsilon 1 |
chr5_-_78985990 | 15.47 |
ENSRNOT00000009248
|
Ambp
|
alpha-1-microglobulin/bikunin precursor |
chr12_+_47407811 | 15.35 |
ENSRNOT00000001565
|
Hnf1a
|
HNF1 homeobox A |
chr1_+_213511874 | 15.33 |
ENSRNOT00000078080
ENSRNOT00000016883 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chrX_-_23144324 | 15.19 |
ENSRNOT00000000178
ENSRNOT00000081239 |
Pfkfb1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr13_+_47572219 | 15.15 |
ENSRNOT00000088449
ENSRNOT00000087664 ENSRNOT00000005853 |
Pigr
|
polymeric immunoglobulin receptor |
chr17_-_417480 | 15.02 |
ENSRNOT00000023685
|
Fbp1
|
fructose-bisphosphatase 1 |
chr1_-_162713610 | 15.01 |
ENSRNOT00000018091
|
Aqp11
|
aquaporin 11 |
chr11_+_88131960 | 14.89 |
ENSRNOT00000046664
|
RGD1308065
|
hypothetical LOC287935 |
chr3_+_170994038 | 14.87 |
ENSRNOT00000081823
|
Spo11
|
SPO11, initiator of meiotic double stranded breaks |
chr9_+_16565225 | 14.87 |
ENSRNOT00000022307
|
Gnmt
|
glycine N-methyltransferase |
chr7_+_130296897 | 14.84 |
ENSRNOT00000044854
|
Adm2
|
adrenomedullin 2 |
chr1_+_20856187 | 14.81 |
ENSRNOT00000071726
|
Smlr1
|
small leucine-rich protein 1 |
chr3_-_7141522 | 14.75 |
ENSRNOT00000014572
|
Cel
|
carboxyl ester lipase |
chr19_+_41710102 | 14.73 |
ENSRNOT00000021866
ENSRNOT00000079730 |
Marveld3
|
MARVEL domain containing 3 |
chr1_+_83711251 | 14.71 |
ENSRNOT00000028237
ENSRNOT00000092008 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr14_-_86164341 | 14.70 |
ENSRNOT00000086343
ENSRNOT00000080147 |
Gck
|
glucokinase |
chr19_+_37090056 | 14.64 |
ENSRNOT00000019169
|
Ces4a
|
carboxylesterase 4A |
chr19_+_9895121 | 14.50 |
ENSRNOT00000033953
|
Prss54
|
protease, serine, 54 |
chr19_-_42180362 | 14.48 |
ENSRNOT00000089515
|
Pmfbp1
|
polyamine modulated factor 1 binding protein 1 |
chr20_-_4934871 | 14.46 |
ENSRNOT00000071840
|
RT1-CE3
|
RT1 class I, locus CE3 |
chr17_+_22620721 | 14.44 |
ENSRNOT00000019478
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr10_-_57243435 | 14.42 |
ENSRNOT00000005050
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit |
chr7_-_73270308 | 14.40 |
ENSRNOT00000007430
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr1_-_98521706 | 14.39 |
ENSRNOT00000015941
|
Siglec10
|
sialic acid binding Ig-like lectin 10 |
chr4_-_170620703 | 14.39 |
ENSRNOT00000011930
|
Plbd1
|
phospholipase B domain containing 1 |
chr16_-_81822716 | 14.37 |
ENSRNOT00000026677
|
F10
|
coagulation factor X |
chr6_+_137243185 | 14.28 |
ENSRNOT00000030879
|
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr18_-_35071619 | 14.22 |
ENSRNOT00000075695
|
LOC100911558
|
serine protease inhibitor Kazal-type 3-like |
chr10_+_56576428 | 14.20 |
ENSRNOT00000079237
ENSRNOT00000023291 |
Cldn7
|
claudin 7 |
chr14_+_22553650 | 14.15 |
ENSRNOT00000092201
ENSRNOT00000002712 |
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr10_-_56426012 | 14.12 |
ENSRNOT00000092506
ENSRNOT00000084068 |
LOC497938
|
similar to RIKEN cDNA 4933402P03 |
chr17_-_30865419 | 14.11 |
ENSRNOT00000022929
|
Fam50b
|
family with sequence similarity 50, member B |
chr2_-_187435323 | 14.08 |
ENSRNOT00000050476
|
Ttc24
|
tetratricopeptide repeat domain 24 |
chr10_+_104019888 | 14.00 |
ENSRNOT00000032016
|
Slc16a5
|
solute carrier family 16 member 5 |
chr7_-_123621102 | 13.91 |
ENSRNOT00000046024
|
Cyp2d5
|
cytochrome P450, family 2, subfamily d, polypeptide 5 |
chr5_-_77342299 | 13.90 |
ENSRNOT00000075994
|
RGD1566134
|
similar to alpha-2u-globulin |
chr3_-_20695952 | 13.90 |
ENSRNOT00000072306
|
AABR07051746.1
|
|
chr1_-_189199376 | 13.89 |
ENSRNOT00000021027
|
Umod
|
uromodulin |
chr19_+_54314865 | 13.83 |
ENSRNOT00000024069
|
Irf8
|
interferon regulatory factor 8 |
chr3_-_80012750 | 13.76 |
ENSRNOT00000018154
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr5_-_59165160 | 13.70 |
ENSRNOT00000029035
|
Fam221b
|
family with sequence similarity 221, member B |
chr5_+_147692391 | 13.68 |
ENSRNOT00000064855
|
Fam229a
|
family with sequence similarity 229, member A |
chr3_-_127500709 | 13.68 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr16_-_21099878 | 13.63 |
ENSRNOT00000027800
|
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr7_-_119689938 | 13.62 |
ENSRNOT00000000200
|
Tmprss6
|
transmembrane protease, serine 6 |
chr1_-_197821936 | 13.58 |
ENSRNOT00000055027
|
Cd19
|
CD19 molecule |
chr1_+_100199057 | 13.53 |
ENSRNOT00000025831
|
Klk1
|
kallikrein 1 |
chr17_+_22619891 | 13.51 |
ENSRNOT00000060403
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr1_+_65576535 | 13.49 |
ENSRNOT00000026575
|
Slc27a5
|
solute carrier family 27 member 5 |
chr3_-_17081510 | 13.45 |
ENSRNOT00000063862
|
AABR07051562.1
|
|
chr13_-_80738634 | 13.44 |
ENSRNOT00000081551
|
Fmo1
|
flavin containing monooxygenase 1 |
chrX_+_134940615 | 13.39 |
ENSRNOT00000005604
|
Xpnpep2
|
X-prolyl aminopeptidase 2 |
chr15_-_34479741 | 13.28 |
ENSRNOT00000027759
|
Ripk3
|
receptor-interacting serine-threonine kinase 3 |
chr10_+_109707962 | 13.25 |
ENSRNOT00000054962
ENSRNOT00000088898 |
Gcgr
|
glucagon receptor |
chr10_+_82775691 | 13.23 |
ENSRNOT00000030737
|
Hils1
|
histone linker H1 domain, spermatid-specific 1 |
chr16_+_20521956 | 13.22 |
ENSRNOT00000026597
|
Pgpep1
|
pyroglutamyl-peptidase I |
chr2_+_181987217 | 13.12 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr7_+_71057911 | 13.11 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr3_-_94686989 | 13.07 |
ENSRNOT00000016677
|
Depdc7
|
DEP domain containing 7 |
chr1_+_282638017 | 13.03 |
ENSRNOT00000079722
ENSRNOT00000082254 |
Ces2c
|
carboxylesterase 2C |
chr1_-_224533219 | 13.03 |
ENSRNOT00000051289
|
Ust5r
|
integral membrane transport protein UST5r |
chr2_+_182006242 | 13.01 |
ENSRNOT00000064091
|
Fga
|
fibrinogen alpha chain |
chr10_+_56662242 | 12.98 |
ENSRNOT00000086919
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr6_-_139142218 | 12.96 |
ENSRNOT00000006975
|
Ighg
|
Immunoglobulin heavy chain (gamma polypeptide) |
chr20_-_8202924 | 12.92 |
ENSRNOT00000071399
|
Tmem217
|
transmembrane protein 217 |
chr1_-_48559162 | 12.90 |
ENSRNOT00000080352
|
Plg
|
plasminogen |
chr1_+_213577122 | 12.90 |
ENSRNOT00000071925
|
RGD1309350
|
similar to transthyretin (4L369) |
chr4_-_50200328 | 12.90 |
ENSRNOT00000060530
|
Aass
|
aminoadipate-semialdehyde synthase |
chr13_+_89774764 | 12.90 |
ENSRNOT00000005619
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr7_-_70643169 | 12.89 |
ENSRNOT00000010106
|
Inhbe
|
inhibin beta E subunit |
chr9_+_95274707 | 12.87 |
ENSRNOT00000045163
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr8_+_127735258 | 12.85 |
ENSRNOT00000015888
|
Vill
|
villin-like |
chr13_+_110511668 | 12.84 |
ENSRNOT00000006235
|
Nek2
|
NIMA-related kinase 2 |
chr8_+_50310405 | 12.78 |
ENSRNOT00000073507
|
Sik3
|
SIK family kinase 3 |
chr2_+_198965685 | 12.77 |
ENSRNOT00000000107
ENSRNOT00000091578 |
Pdzk1
|
PDZ domain containing 1 |
chr7_-_30105132 | 12.76 |
ENSRNOT00000091227
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr10_-_97756521 | 12.75 |
ENSRNOT00000045902
|
Slc16a6
|
solute carrier family 16, member 6 |
chr17_+_25082056 | 12.73 |
ENSRNOT00000037041
|
AABR07027339.1
|
|
chr1_-_98521551 | 12.70 |
ENSRNOT00000081922
|
Siglec10
|
sialic acid binding Ig-like lectin 10 |
chr1_+_229039889 | 12.68 |
ENSRNOT00000054800
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr10_+_90085559 | 12.64 |
ENSRNOT00000028332
|
Nags
|
N-acetylglutamate synthase |
chr8_-_115274165 | 12.50 |
ENSRNOT00000056386
|
LOC102550160
|
IQ domain-containing protein F5-like |
chr9_+_67546408 | 12.49 |
ENSRNOT00000013701
|
Cd28
|
Cd28 molecule |
chr1_+_282567674 | 12.48 |
ENSRNOT00000090543
|
Ces2i
|
carboxylesterase 2I |
chr1_-_73682247 | 12.47 |
ENSRNOT00000079498
|
Lilra5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
chr15_+_2526368 | 12.45 |
ENSRNOT00000048713
ENSRNOT00000074803 |
Dusp13
Dusp13
|
dual specificity phosphatase 13 dual specificity phosphatase 13 |
chr9_-_101038625 | 12.41 |
ENSRNOT00000025743
|
Pdcd1
|
programmed cell death 1 |
chr12_+_38828444 | 12.41 |
ENSRNOT00000001809
|
Hpd
|
4-hydroxyphenylpyruvate dioxygenase |
chr4_+_170958196 | 12.41 |
ENSRNOT00000007905
|
Pde6h
|
phosphodiesterase 6H |
chr7_+_70452579 | 12.39 |
ENSRNOT00000046099
|
B4galnt1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
chr13_-_74740458 | 12.35 |
ENSRNOT00000006548
|
Tex35
|
testis expressed 35 |
chr20_+_4039413 | 12.25 |
ENSRNOT00000082136
|
RT1-Bb
|
RT1 class II, locus Bb |
chr2_-_211322719 | 12.23 |
ENSRNOT00000027493
|
RGD1310209
|
similar to KIAA1324 protein |
chr1_+_100086520 | 12.10 |
ENSRNOT00000025723
|
Klk1
|
kallikrein 1 |
chr6_+_137184820 | 12.03 |
ENSRNOT00000073796
|
Adssl1
|
adenylosuccinate synthase like 1 |
chr15_+_4554603 | 12.00 |
ENSRNOT00000075153
|
Kcnk5
|
potassium two pore domain channel subfamily K member 5 |
chr1_-_80744831 | 11.99 |
ENSRNOT00000025913
|
Bcl3
|
B-cell CLL/lymphoma 3 |
chrX_-_135342996 | 11.97 |
ENSRNOT00000084848
ENSRNOT00000008503 |
Aifm1
|
apoptosis inducing factor, mitochondria associated 1 |
chr7_-_123655896 | 11.97 |
ENSRNOT00000012413
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2 |
chr8_+_22856539 | 11.95 |
ENSRNOT00000015381
|
Angptl8
|
angiopoietin-like 8 |
chr1_+_167197549 | 11.93 |
ENSRNOT00000027427
|
Art1
|
ADP-ribosyltransferase 1 |
chr7_-_142318620 | 11.93 |
ENSRNOT00000006351
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr10_-_90410569 | 11.89 |
ENSRNOT00000036112
|
Itga2b
|
integrin subunit alpha 2b |
chr1_+_141821916 | 11.82 |
ENSRNOT00000071574
|
Echs1
|
enoyl-CoA hydratase, short chain 1 |
chr19_-_42180981 | 11.80 |
ENSRNOT00000019577
|
Pmfbp1
|
polyamine modulated factor 1 binding protein 1 |
chr3_-_176744377 | 11.80 |
ENSRNOT00000017787
|
Helz2
|
helicase with zinc finger 2, transcriptional coactivator |
chr9_+_100281339 | 11.73 |
ENSRNOT00000029127
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr4_-_69268336 | 11.71 |
ENSRNOT00000018042
|
Prss3b
|
protease, serine, 3B |
chr11_+_86092468 | 11.70 |
ENSRNOT00000057971
|
LOC100361706
|
lambda-chain C1-region-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.4 | 65.7 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
12.0 | 36.1 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
11.3 | 33.8 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) formamide metabolic process(GO:0043606) |
11.0 | 22.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
9.9 | 29.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
9.4 | 28.3 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) oxalic acid secretion(GO:0046724) |
9.3 | 27.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
8.3 | 24.9 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
8.0 | 8.0 | GO:0006554 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
8.0 | 31.9 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
7.8 | 62.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
7.3 | 58.4 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
7.0 | 35.0 | GO:0015793 | glycerol transport(GO:0015793) |
6.9 | 20.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
6.7 | 26.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
6.7 | 20.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
6.4 | 121.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
6.2 | 12.5 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
6.2 | 18.7 | GO:0034769 | basement membrane disassembly(GO:0034769) |
6.2 | 37.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
6.2 | 24.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
6.1 | 24.5 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
6.1 | 42.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
5.8 | 52.3 | GO:0046618 | drug export(GO:0046618) |
5.8 | 29.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
5.8 | 23.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
5.7 | 28.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
5.7 | 22.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
5.6 | 22.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
5.6 | 16.9 | GO:0051977 | lysophospholipid transport(GO:0051977) |
5.4 | 43.4 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
5.4 | 5.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
5.3 | 26.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.3 | 21.2 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
5.3 | 15.8 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
5.2 | 5.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
5.1 | 20.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
5.1 | 35.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
5.1 | 46.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
5.1 | 20.4 | GO:0035565 | regulation of pronephros size(GO:0035565) |
5.1 | 5.1 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
5.1 | 10.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
5.1 | 15.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
5.0 | 49.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
4.9 | 24.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
4.8 | 19.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
4.7 | 14.2 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
4.7 | 18.9 | GO:0030221 | basophil differentiation(GO:0030221) |
4.7 | 14.1 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
4.4 | 13.3 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
4.4 | 13.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
4.3 | 12.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.2 | 8.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
4.0 | 8.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
4.0 | 12.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
4.0 | 32.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
4.0 | 12.0 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
3.9 | 15.7 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
3.9 | 15.7 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
3.9 | 23.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
3.9 | 15.7 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
3.9 | 15.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
3.9 | 15.6 | GO:1990478 | response to ultrasound(GO:1990478) |
3.9 | 15.5 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
3.8 | 15.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
3.8 | 11.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
3.7 | 15.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
3.7 | 7.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
3.7 | 7.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
3.7 | 11.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
3.7 | 11.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.7 | 29.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
3.6 | 14.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
3.6 | 3.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
3.6 | 18.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.6 | 29.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
3.6 | 10.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
3.6 | 10.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
3.5 | 10.6 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
3.5 | 38.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
3.5 | 10.6 | GO:1901143 | insulin catabolic process(GO:1901143) |
3.5 | 7.0 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
3.5 | 3.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.5 | 6.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
3.5 | 10.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
3.4 | 24.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.4 | 20.6 | GO:0031427 | response to methotrexate(GO:0031427) |
3.4 | 13.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
3.4 | 13.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
3.4 | 10.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
3.4 | 10.2 | GO:0010034 | response to acetate(GO:0010034) |
3.4 | 13.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.3 | 10.0 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
3.3 | 33.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
3.3 | 9.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
3.3 | 6.6 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
3.3 | 19.8 | GO:0070541 | response to platinum ion(GO:0070541) |
3.2 | 12.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
3.2 | 9.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.2 | 16.0 | GO:1904970 | brush border assembly(GO:1904970) |
3.2 | 25.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.2 | 12.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
3.2 | 12.8 | GO:0015879 | carnitine transport(GO:0015879) |
3.2 | 12.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
3.1 | 9.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
3.1 | 9.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.1 | 21.9 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
3.1 | 9.2 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
3.0 | 12.0 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
3.0 | 29.9 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
3.0 | 14.9 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
3.0 | 8.9 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
2.9 | 20.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
2.9 | 8.7 | GO:0070543 | response to linoleic acid(GO:0070543) |
2.9 | 5.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
2.8 | 25.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.8 | 8.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.8 | 2.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
2.8 | 8.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.8 | 16.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.8 | 11.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.7 | 49.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
2.7 | 16.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.7 | 13.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.7 | 10.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.7 | 16.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.6 | 2.6 | GO:0070268 | cornification(GO:0070268) |
2.6 | 2.6 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
2.6 | 13.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.6 | 10.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.6 | 18.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.6 | 2.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
2.6 | 5.2 | GO:0010037 | response to carbon dioxide(GO:0010037) |
2.5 | 7.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
2.5 | 7.6 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.5 | 17.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
2.5 | 45.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.5 | 2.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.5 | 9.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.5 | 12.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.5 | 27.1 | GO:0042730 | fibrinolysis(GO:0042730) |
2.5 | 12.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.5 | 7.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
2.4 | 22.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
2.4 | 9.8 | GO:1903015 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) regulation of exo-alpha-sialidase activity(GO:1903015) |
2.4 | 7.3 | GO:0046967 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
2.4 | 4.8 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
2.4 | 2.4 | GO:0010266 | response to vitamin B1(GO:0010266) |
2.4 | 12.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.4 | 4.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.4 | 9.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
2.4 | 9.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
2.4 | 11.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.4 | 2.4 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
2.3 | 7.0 | GO:0002432 | granuloma formation(GO:0002432) |
2.3 | 21.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
2.3 | 7.0 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
2.3 | 11.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.3 | 34.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
2.3 | 4.6 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
2.3 | 4.6 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
2.3 | 6.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
2.3 | 4.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
2.3 | 4.5 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
2.3 | 6.8 | GO:0030578 | PML body organization(GO:0030578) |
2.3 | 9.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.3 | 6.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.3 | 9.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.3 | 9.0 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.2 | 22.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.2 | 4.4 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
2.2 | 6.6 | GO:0009216 | AMP biosynthetic process(GO:0006167) purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) AMP salvage(GO:0044209) adenosine biosynthetic process(GO:0046086) |
2.2 | 4.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
2.2 | 6.6 | GO:0060128 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
2.2 | 2.2 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 6.6 | GO:0033986 | response to methanol(GO:0033986) |
2.2 | 19.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
2.2 | 6.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.2 | 6.5 | GO:0021539 | subthalamus development(GO:0021539) |
2.2 | 6.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
2.2 | 17.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.2 | 17.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
2.2 | 36.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.2 | 6.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
2.1 | 10.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
2.1 | 17.0 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
2.1 | 6.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.1 | 10.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
2.1 | 16.8 | GO:0015747 | urate transport(GO:0015747) |
2.1 | 6.3 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.1 | 47.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.1 | 20.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.1 | 4.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.0 | 14.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.0 | 14.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
2.0 | 10.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.0 | 6.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
2.0 | 2.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
2.0 | 10.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.0 | 4.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.0 | 8.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.0 | 6.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
2.0 | 6.0 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
2.0 | 6.0 | GO:2000521 | negative regulation of cell proliferation in bone marrow(GO:1903769) negative regulation of immunological synapse formation(GO:2000521) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
2.0 | 6.0 | GO:0019677 | NAD catabolic process(GO:0019677) |
2.0 | 8.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
2.0 | 13.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
2.0 | 2.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
2.0 | 13.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.9 | 7.8 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
1.9 | 9.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.9 | 7.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.9 | 9.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
1.9 | 17.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.9 | 5.8 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
1.9 | 7.7 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.9 | 11.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.9 | 15.3 | GO:0032782 | bile acid secretion(GO:0032782) |
1.9 | 7.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.9 | 5.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.9 | 1.9 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
1.9 | 3.8 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
1.9 | 3.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.9 | 5.6 | GO:0030091 | protein repair(GO:0030091) |
1.9 | 5.6 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
1.9 | 18.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.9 | 7.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.8 | 3.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.8 | 3.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.8 | 14.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
1.8 | 25.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.8 | 9.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.8 | 7.2 | GO:0051958 | methotrexate transport(GO:0051958) |
1.8 | 3.6 | GO:0006710 | androgen catabolic process(GO:0006710) |
1.8 | 5.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.8 | 7.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.8 | 3.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.7 | 8.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) generation of ovulation cycle rhythm(GO:0060112) |
1.7 | 6.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.7 | 5.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.7 | 5.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.7 | 39.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.7 | 8.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
1.7 | 57.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.7 | 23.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.7 | 1.7 | GO:0071217 | cellular response to external biotic stimulus(GO:0071217) |
1.7 | 6.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.7 | 5.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.6 | 9.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.6 | 3.3 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.6 | 8.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.6 | 1.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.6 | 42.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.6 | 18.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.6 | 8.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
1.6 | 3.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.6 | 4.8 | GO:1904380 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) endoplasmic reticulum mannose trimming(GO:1904380) |
1.6 | 3.2 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
1.6 | 3.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.6 | 4.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.6 | 1.6 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.6 | 12.7 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.6 | 14.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.6 | 25.2 | GO:0051923 | sulfation(GO:0051923) |
1.6 | 3.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.6 | 4.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.6 | 25.1 | GO:0006956 | complement activation(GO:0006956) |
1.6 | 4.7 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.6 | 4.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.6 | 4.7 | GO:0003032 | detection of oxygen(GO:0003032) |
1.6 | 4.7 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.6 | 4.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.6 | 4.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.5 | 9.2 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
1.5 | 21.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.5 | 4.6 | GO:2000502 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) negative regulation of natural killer cell chemotaxis(GO:2000502) |
1.5 | 4.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.5 | 7.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.5 | 4.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
1.5 | 36.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.5 | 3.0 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
1.5 | 1.5 | GO:0032978 | protein insertion into membrane from inner side(GO:0032978) |
1.5 | 7.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.5 | 7.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.5 | 11.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
1.5 | 4.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.5 | 5.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.5 | 7.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.5 | 14.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.5 | 10.2 | GO:0015886 | heme transport(GO:0015886) |
1.5 | 11.7 | GO:0046415 | urate metabolic process(GO:0046415) |
1.5 | 29.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.5 | 2.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.5 | 2.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.4 | 5.8 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
1.4 | 18.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.4 | 11.5 | GO:1903232 | melanosome assembly(GO:1903232) |
1.4 | 7.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.4 | 2.9 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
1.4 | 2.9 | GO:0019541 | propionate metabolic process(GO:0019541) |
1.4 | 7.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.4 | 41.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.4 | 2.8 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.4 | 2.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.4 | 14.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
1.4 | 4.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.4 | 19.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.4 | 2.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 6.9 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.4 | 4.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.4 | 13.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.3 | 8.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.3 | 5.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.3 | 4.0 | GO:1901367 | response to L-cysteine(GO:1901367) |
1.3 | 9.4 | GO:0007144 | female meiosis I(GO:0007144) |
1.3 | 17.4 | GO:0015677 | copper ion import(GO:0015677) |
1.3 | 2.7 | GO:0018963 | phthalate metabolic process(GO:0018963) |
1.3 | 1.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.3 | 19.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.3 | 3.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.3 | 3.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
1.3 | 3.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.3 | 2.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.3 | 5.2 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
1.3 | 6.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.3 | 2.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
1.3 | 7.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.3 | 10.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.3 | 6.4 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
1.3 | 8.9 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
1.3 | 1.3 | GO:0042197 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.3 | 3.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.3 | 6.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 1.3 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
1.3 | 7.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.3 | 17.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.2 | 6.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.2 | 41.1 | GO:0030261 | chromosome condensation(GO:0030261) |
1.2 | 6.2 | GO:0002606 | regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.2 | 13.6 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.2 | 11.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.2 | 2.5 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
1.2 | 20.9 | GO:0042168 | heme metabolic process(GO:0042168) |
1.2 | 2.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.2 | 3.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.2 | 3.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.2 | 2.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.2 | 11.0 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
1.2 | 6.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
1.2 | 4.8 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
1.2 | 7.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.2 | 13.0 | GO:0034389 | lipid particle organization(GO:0034389) |
1.2 | 8.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.2 | 3.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.2 | 4.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
1.2 | 1.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.2 | 2.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
1.2 | 12.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.2 | 14.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
1.2 | 16.4 | GO:0015671 | oxygen transport(GO:0015671) |
1.2 | 2.3 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
1.2 | 51.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.2 | 3.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
1.2 | 8.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.2 | 3.5 | GO:0048749 | compound eye development(GO:0048749) |
1.2 | 9.3 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 6.9 | GO:0060056 | mammary gland involution(GO:0060056) |
1.1 | 11.5 | GO:0002934 | desmosome organization(GO:0002934) |
1.1 | 5.7 | GO:0060005 | vestibular reflex(GO:0060005) |
1.1 | 47.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.1 | 6.8 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
1.1 | 11.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.1 | 3.4 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 2.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 4.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.1 | 6.7 | GO:0034312 | diol biosynthetic process(GO:0034312) |
1.1 | 2.2 | GO:0034034 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
1.1 | 2.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.1 | 6.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.1 | 9.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.1 | 7.7 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
1.1 | 4.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.1 | 2.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.1 | 2.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
1.1 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.1 | 4.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.1 | 2.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.1 | 9.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 2.2 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.1 | 3.2 | GO:0061317 | canonical Wnt signaling pathway involved in heart development(GO:0061316) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
1.1 | 3.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.1 | 1.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.1 | 9.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.1 | 11.8 | GO:0070166 | enamel mineralization(GO:0070166) |
1.1 | 6.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.1 | 9.6 | GO:0048102 | autophagic cell death(GO:0048102) |
1.1 | 5.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.1 | 2.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
1.1 | 7.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.0 | 2.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 2.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
1.0 | 9.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
1.0 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.0 | 4.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 4.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
1.0 | 8.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.0 | 2.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.0 | 3.0 | GO:0009751 | response to salicylic acid(GO:0009751) |
1.0 | 21.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.0 | 5.0 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
1.0 | 17.8 | GO:0019835 | cytolysis(GO:0019835) |
1.0 | 7.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.0 | 2.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.0 | 4.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.0 | 1.9 | GO:0002032 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.0 | 5.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.0 | 3.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.0 | 10.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.0 | 2.9 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.0 | 9.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.0 | 1.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.0 | 3.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.0 | 3.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.0 | 2.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.9 | 43.7 | GO:0032094 | response to food(GO:0032094) |
0.9 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.9 | 4.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.9 | 4.7 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.9 | 19.7 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.9 | 7.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.9 | 4.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.9 | 3.7 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.9 | 2.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.9 | 4.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.9 | 2.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.9 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 12.0 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 6.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.9 | 3.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.9 | 14.6 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.9 | 1.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.9 | 2.7 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.9 | 3.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.9 | 5.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.9 | 2.7 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.9 | 3.6 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.9 | 5.4 | GO:0015866 | ADP transport(GO:0015866) |
0.9 | 3.6 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.9 | 8.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.9 | 2.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 5.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 3.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.9 | 2.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.9 | 2.6 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.9 | 4.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.9 | 2.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 4.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.9 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.9 | 5.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 2.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 2.6 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.9 | 2.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.9 | 1.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.9 | 6.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.8 | 0.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.8 | 5.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.8 | 8.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 0.8 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.8 | 31.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.8 | 2.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.8 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 4.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.8 | 2.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 4.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 13.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.8 | 20.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.8 | 8.9 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.8 | 5.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.8 | 8.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 3.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.8 | 2.4 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.8 | 6.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 0.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.8 | 4.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 5.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.8 | 3.9 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.8 | 13.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.8 | 3.1 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.8 | 16.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 3.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.8 | 9.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 3.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 3.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 5.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.8 | 2.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.8 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.8 | 6.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 3.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 6.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 3.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 5.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 1.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.7 | 11.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.7 | 2.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.7 | 0.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.7 | 0.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 6.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.7 | 5.7 | GO:0002467 | germinal center formation(GO:0002467) |
0.7 | 6.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.7 | 6.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 7.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.7 | 3.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 2.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.7 | 3.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 2.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.7 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 6.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.7 | 2.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.7 | 3.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 4.8 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.7 | 7.6 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.7 | 2.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.7 | 2.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 8.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.7 | 6.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.7 | 8.8 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.7 | 4.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 6.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 2.0 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
0.7 | 6.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 11.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.7 | 2.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.7 | 9.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.7 | 6.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 4.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.7 | 7.2 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.7 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.6 | 3.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.6 | 1.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.6 | 3.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.6 | 18.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.6 | 2.5 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.6 | 7.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.6 | 1.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 8.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.6 | 1.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.6 | 1.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 1.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.6 | 2.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.6 | 3.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 3.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 3.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.6 | 4.9 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.6 | 2.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 1.2 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.6 | 6.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 4.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 1.2 | GO:0072181 | kidney rudiment formation(GO:0072003) nephric duct formation(GO:0072179) mesonephric duct formation(GO:0072181) |
0.6 | 2.9 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.6 | 1.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.6 | 15.8 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.6 | 1.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.6 | 11.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 4.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.6 | 3.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.6 | 9.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.6 | 27.4 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.6 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.6 | 39.8 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.6 | 4.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 12.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 5.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 5.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.6 | 3.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.6 | 1.7 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.6 | 4.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.6 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 6.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 7.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.6 | 3.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 7.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.6 | 1.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 2.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.6 | 5.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.5 | 2.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 9.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.5 | 6.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 6.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 3.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.5 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 4.3 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.5 | 2.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 4.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.5 | 2.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.5 | 3.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 11.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.5 | 1.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 1.0 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) |
0.5 | 10.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.5 | 2.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 2.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 1.5 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 3.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 0.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 3.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 1.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.5 | 4.1 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.5 | 2.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.5 | 7.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 3.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 2.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.5 | 1.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.5 | 5.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 1.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 7.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.5 | 13.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 2.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.5 | 1.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 4.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 0.9 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
0.5 | 1.9 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.5 | 1.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 2.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.5 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 2.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 1.4 | GO:2000739 | regulation of aldosterone biosynthetic process(GO:0032347) regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.5 | 5.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.5 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 9.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 3.6 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.4 | 4.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 4.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 1.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 8.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 5.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.4 | 3.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.4 | 1.3 | GO:0009758 | carbohydrate utilization(GO:0009758) |
0.4 | 0.8 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.4 | 0.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 5.5 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 8.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.8 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 5.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 1.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 3.3 | GO:0030238 | male sex determination(GO:0030238) |
0.4 | 1.7 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.4 | 1.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 2.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 6.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 2.0 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.4 | 10.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 1.2 | GO:0010045 | response to nickel cation(GO:0010045) |
0.4 | 2.4 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 3.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 1.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.4 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.8 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.4 | 4.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 1.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 2.3 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 2.3 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 1.5 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.4 | 0.7 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.4 | 1.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 2.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 0.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.7 | GO:1904373 | response to kainic acid(GO:1904373) |
0.4 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 2.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.4 | 2.5 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.4 | 2.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 4.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 2.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 2.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 3.7 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.3 | 1.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.7 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.3 | 2.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 2.0 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.3 | 2.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 6.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 5.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 1.9 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.3 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.3 | 2.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.6 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.3 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 2.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 1.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 3.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 1.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 1.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 1.1 | GO:1990646 | cellular response to prolactin(GO:1990646) |
0.3 | 0.3 | GO:0033197 | response to vitamin E(GO:0033197) |
0.3 | 1.1 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 2.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 3.6 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.3 | 0.8 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 4.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 2.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 2.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 5.4 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.8 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.3 | 13.4 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 7.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 2.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 1.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.7 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 2.7 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 1.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 2.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.2 | 1.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 1.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.7 | GO:1901536 | protection of DNA demethylation of female pronucleus(GO:0044726) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 2.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 2.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 4.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.9 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.5 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 1.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 3.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.8 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.2 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 6.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 8.2 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.2 | 1.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 3.6 | GO:0019068 | virion assembly(GO:0019068) |
0.2 | 0.6 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.2 | 4.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.7 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 1.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 3.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.2 | 0.6 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 1.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.8 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 2.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 1.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 1.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 1.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 1.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 5.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 1.4 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 1.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 2.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) embryonic liver development(GO:1990402) |
0.2 | 2.6 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 8.7 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.2 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 4.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 1.0 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 5.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 1.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 6.1 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.2 | 0.7 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 0.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 2.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.1 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.2 | 5.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 2.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 2.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 1.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.6 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.9 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 1.9 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 3.1 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 1.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 1.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.1 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.9 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.3 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 1.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 3.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.8 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 1.2 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.4 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.7 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.3 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.9 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 2.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 2.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 3.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.2 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.8 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 5.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 9.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 2.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 2.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.2 | GO:0032919 | spermine acetylation(GO:0032919) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 1.5 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 50.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.0 | 0.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 2.1 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.2 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 1.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 41.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
9.5 | 76.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
8.1 | 24.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
7.6 | 98.3 | GO:0042627 | chylomicron(GO:0042627) |
6.8 | 33.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
5.9 | 23.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
5.1 | 30.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
4.6 | 4.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
4.3 | 85.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
4.3 | 55.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
4.3 | 68.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
4.2 | 62.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.6 | 21.6 | GO:0097342 | ripoptosome(GO:0097342) |
3.5 | 24.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
3.3 | 13.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.0 | 21.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.0 | 36.1 | GO:0005861 | troponin complex(GO:0005861) |
3.0 | 23.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.9 | 8.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
2.9 | 11.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
2.6 | 7.7 | GO:0005745 | m-AAA complex(GO:0005745) |
2.5 | 7.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
2.3 | 25.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.2 | 15.6 | GO:0031415 | NatA complex(GO:0031415) |
2.2 | 17.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.2 | 6.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
2.1 | 6.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
2.1 | 8.4 | GO:0070876 | SOSS complex(GO:0070876) |
2.0 | 6.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
1.9 | 1.9 | GO:0045281 | respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) |
1.9 | 11.5 | GO:0031904 | endosome lumen(GO:0031904) |
1.9 | 204.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.9 | 5.7 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.9 | 14.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.9 | 5.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
1.8 | 7.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.8 | 5.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.7 | 6.9 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
1.7 | 16.8 | GO:0042587 | glycogen granule(GO:0042587) |
1.6 | 14.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.6 | 20.5 | GO:0031983 | vesicle lumen(GO:0031983) |
1.5 | 4.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.5 | 6.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
1.5 | 35.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.5 | 110.3 | GO:0045095 | keratin filament(GO:0045095) |
1.5 | 11.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.5 | 10.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 12.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.4 | 24.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.4 | 4.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
1.4 | 26.3 | GO:0001520 | outer dense fiber(GO:0001520) |
1.4 | 29.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.4 | 2.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.3 | 20.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.3 | 10.6 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
1.3 | 5.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
1.3 | 6.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.3 | 5.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
1.3 | 2.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.3 | 26.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.3 | 7.6 | GO:0071547 | piP-body(GO:0071547) |
1.3 | 3.8 | GO:0031308 | intrinsic component of nuclear outer membrane(GO:0031308) integral component of nuclear outer membrane(GO:0031309) |
1.3 | 13.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
1.3 | 3.8 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.2 | 2.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
1.2 | 6.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.2 | 25.8 | GO:0031528 | microvillus membrane(GO:0031528) |
1.2 | 8.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.2 | 7.2 | GO:0036128 | CatSper complex(GO:0036128) |
1.2 | 7.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 3.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.2 | 3.5 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.1 | 4.6 | GO:0072487 | MSL complex(GO:0072487) |
1.1 | 4.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.1 | 10.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 17.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.1 | 5.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.1 | 4.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.1 | 15.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.1 | 8.6 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 4.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 3.2 | GO:1990037 | Lewy body core(GO:1990037) |
1.1 | 20.1 | GO:0030057 | desmosome(GO:0030057) |
1.1 | 19.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 11.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.0 | 5.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.0 | 7.3 | GO:0070449 | elongin complex(GO:0070449) |
1.0 | 9.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.0 | 3.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.0 | 3.0 | GO:0055087 | Ski complex(GO:0055087) |
1.0 | 2.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.9 | 6.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.9 | 3.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.9 | 3.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.9 | 2.8 | GO:0061474 | phagolysosome(GO:0032010) phagolysosome membrane(GO:0061474) |
0.9 | 2.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 5.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.9 | 3.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.9 | 4.6 | GO:0032059 | bleb(GO:0032059) |
0.9 | 2.7 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
0.9 | 13.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 6.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.9 | 107.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.9 | 16.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.9 | 4.3 | GO:0098536 | deuterosome(GO:0098536) |
0.9 | 2.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.8 | 16.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 62.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 18.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 25.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.8 | 13.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.8 | 4.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.8 | 4.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 14.4 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 3.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 3.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.7 | 8.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 3.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 3.6 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 4.3 | GO:0071546 | pi-body(GO:0071546) |
0.7 | 2.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 5.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 5.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 7.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 12.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.7 | 2.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 3.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 6.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 7.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 2.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 10.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 4.3 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 35.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.6 | 3.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 4.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 66.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.6 | 2.3 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 15.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 1.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.6 | 26.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 28.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 15.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 2.7 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
0.5 | 128.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 2.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 4.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 23.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.5 | 7.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 10.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 31.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.5 | 150.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 2.6 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.5 | 9.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 2.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 8.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 2.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 6.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.5 | 1.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 2.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.5 | 1.5 | GO:0044307 | dendritic branch(GO:0044307) |
0.5 | 54.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 30.4 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 2.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 2.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 1.9 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 2.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 2.3 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 3.5 | GO:0002177 | manchette(GO:0002177) |
0.4 | 29.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 3.9 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 2.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 10.0 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 2.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 35.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.4 | 0.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 39.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 1.8 | GO:0034455 | t-UTP complex(GO:0034455) |
0.4 | 3.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 3.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 12.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 3.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 4.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 3.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 3.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 3.9 | GO:0000801 | central element(GO:0000801) |
0.3 | 3.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 17.6 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 2.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.3 | 5.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.2 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 4.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 4.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 4.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 3.8 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 4.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 12.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 6.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 2.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 17.1 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 8.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 7.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 6.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 101.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 6.9 | GO:0005903 | brush border(GO:0005903) |
0.2 | 193.3 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 2.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 14.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 4.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 3.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 2.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 2.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 9.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 4.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 0.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 5.1 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.9 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 5.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.9 | 47.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
12.9 | 38.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
10.5 | 42.0 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
9.9 | 49.4 | GO:0005550 | pheromone binding(GO:0005550) |
9.5 | 47.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
8.4 | 42.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
7.8 | 39.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
7.5 | 29.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
7.3 | 29.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
6.8 | 20.4 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
6.7 | 53.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
6.7 | 20.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.4 | 19.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
6.3 | 31.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
6.0 | 18.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
5.6 | 16.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
5.6 | 16.9 | GO:0032810 | sterol response element binding(GO:0032810) |
5.5 | 11.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
5.5 | 38.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
5.2 | 15.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
5.1 | 15.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
5.0 | 20.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
5.0 | 14.9 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
4.9 | 44.5 | GO:0032052 | bile acid binding(GO:0032052) |
4.9 | 19.4 | GO:0019862 | IgA binding(GO:0019862) |
4.7 | 14.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
4.7 | 14.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
4.7 | 32.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
4.7 | 23.3 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
4.6 | 18.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
4.5 | 54.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
4.4 | 13.3 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
4.4 | 35.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.4 | 35.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
4.3 | 13.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
4.3 | 4.3 | GO:0043176 | amine binding(GO:0043176) |
4.2 | 16.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
4.2 | 58.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
4.1 | 16.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
4.1 | 24.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
4.1 | 24.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
4.0 | 24.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.9 | 35.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
3.8 | 34.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.8 | 3.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
3.6 | 18.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
3.6 | 10.8 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.6 | 25.2 | GO:0031433 | telethonin binding(GO:0031433) |
3.6 | 25.0 | GO:0031014 | troponin T binding(GO:0031014) |
3.6 | 85.5 | GO:0070330 | aromatase activity(GO:0070330) |
3.5 | 17.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
3.5 | 89.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
3.4 | 6.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.4 | 10.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.4 | 13.7 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) |
3.4 | 34.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.4 | 20.4 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.4 | 23.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
3.3 | 13.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
3.3 | 13.1 | GO:0004064 | arylesterase activity(GO:0004064) |
3.2 | 13.0 | GO:0030984 | kininogen binding(GO:0030984) |
3.2 | 12.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
3.2 | 19.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.1 | 15.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
3.1 | 25.0 | GO:0008430 | selenium binding(GO:0008430) |
3.1 | 24.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
3.1 | 3.1 | GO:0038132 | neuregulin binding(GO:0038132) |
3.0 | 8.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
3.0 | 11.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.0 | 47.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
3.0 | 8.9 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
3.0 | 8.9 | GO:0019807 | aspartoacylase activity(GO:0019807) |
2.9 | 11.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.9 | 26.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.9 | 8.8 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
2.9 | 17.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.9 | 11.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.9 | 8.7 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
2.9 | 8.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.8 | 8.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
2.8 | 11.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
2.8 | 8.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.8 | 49.9 | GO:0001848 | complement binding(GO:0001848) |
2.8 | 8.3 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
2.7 | 19.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.7 | 8.1 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
2.7 | 16.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
2.7 | 8.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.6 | 5.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.6 | 7.9 | GO:0016015 | morphogen activity(GO:0016015) |
2.6 | 18.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.6 | 93.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
2.6 | 10.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.6 | 10.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.5 | 27.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
2.5 | 7.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
2.5 | 7.4 | GO:0016414 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
2.4 | 24.2 | GO:0039706 | co-receptor binding(GO:0039706) |
2.4 | 7.2 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
2.4 | 16.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.4 | 9.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
2.4 | 42.9 | GO:0043295 | glutathione binding(GO:0043295) |
2.4 | 9.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
2.4 | 18.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.3 | 2.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.3 | 9.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.2 | 13.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.2 | 8.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.2 | 6.7 | GO:0004040 | amidase activity(GO:0004040) |
2.2 | 8.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.2 | 6.6 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
2.2 | 19.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.2 | 13.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
2.2 | 6.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.2 | 67.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
2.2 | 13.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
2.2 | 6.5 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
2.1 | 17.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
2.1 | 10.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
2.1 | 16.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.1 | 18.9 | GO:0015232 | heme transporter activity(GO:0015232) |
2.1 | 6.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.1 | 8.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.1 | 8.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.1 | 20.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.0 | 6.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
2.0 | 10.1 | GO:0043532 | angiostatin binding(GO:0043532) |
2.0 | 437.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.0 | 15.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.0 | 6.0 | GO:0004359 | glutaminase activity(GO:0004359) |
2.0 | 5.9 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
2.0 | 11.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.0 | 11.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.9 | 1.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.9 | 7.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
1.9 | 9.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.9 | 3.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.9 | 5.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.9 | 13.2 | GO:0035375 | zymogen binding(GO:0035375) |
1.9 | 5.6 | GO:0042806 | fucose binding(GO:0042806) |
1.9 | 5.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.9 | 11.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.8 | 1.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.8 | 16.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.8 | 9.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.8 | 18.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.8 | 16.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.8 | 9.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.8 | 14.4 | GO:0019864 | IgG binding(GO:0019864) |
1.8 | 5.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.8 | 8.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.8 | 5.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
1.8 | 5.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.8 | 7.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.7 | 35.0 | GO:0008199 | ferric iron binding(GO:0008199) |
1.7 | 29.6 | GO:0070402 | NADPH binding(GO:0070402) |
1.7 | 12.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.7 | 8.5 | GO:0004103 | choline kinase activity(GO:0004103) |
1.7 | 8.4 | GO:0005499 | vitamin D binding(GO:0005499) |
1.7 | 5.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.7 | 15.0 | GO:0015250 | water channel activity(GO:0015250) |
1.7 | 19.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.6 | 13.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.6 | 4.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.6 | 13.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.6 | 6.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.6 | 31.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.6 | 3.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.6 | 6.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
1.6 | 12.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.6 | 4.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.6 | 24.9 | GO:0019825 | oxygen binding(GO:0019825) |
1.5 | 4.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 10.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.5 | 3.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.5 | 4.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.5 | 3.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.5 | 5.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 10.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.5 | 4.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.4 | 2.9 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
1.4 | 11.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.4 | 14.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.4 | 24.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 5.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.4 | 5.5 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
1.4 | 5.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.4 | 5.5 | GO:0035877 | death effector domain binding(GO:0035877) |
1.4 | 17.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.4 | 11.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 4.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.4 | 9.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.4 | 17.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.3 | 8.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 4.0 | GO:0003922 | GMP synthase activity(GO:0003921) GMP synthase (glutamine-hydrolyzing) activity(GO:0003922) |
1.3 | 5.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.3 | 2.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.3 | 6.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.3 | 6.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.3 | 6.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 1.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.3 | 5.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.3 | 5.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.3 | 3.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.3 | 5.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.3 | 3.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.3 | 10.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.3 | 5.0 | GO:0045159 | myosin II binding(GO:0045159) |
1.3 | 3.8 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.2 | 7.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.2 | 3.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.2 | 7.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.2 | 6.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.2 | 3.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.2 | 13.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 6.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.2 | 3.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.2 | 8.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.2 | 3.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.2 | 3.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 22.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.1 | 20.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.1 | 13.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 2.3 | GO:0032564 | dATP binding(GO:0032564) |
1.1 | 7.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 7.9 | GO:0043559 | insulin binding(GO:0043559) |
1.1 | 10.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.1 | 3.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
1.1 | 6.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 2.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.1 | 12.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.1 | 2.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.1 | 6.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.1 | 3.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.1 | 7.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.1 | 6.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.1 | 121.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.1 | 10.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.1 | 32.7 | GO:0004601 | peroxidase activity(GO:0004601) |
1.0 | 23.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.0 | 6.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.0 | 2.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.0 | 5.2 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
1.0 | 10.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.0 | 5.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.0 | 3.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.0 | 3.0 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
1.0 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.0 | 9.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.0 | 3.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.0 | 63.9 | GO:0020037 | heme binding(GO:0020037) |
1.0 | 6.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.0 | 10.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.0 | 8.7 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 12.5 | GO:0015026 | coreceptor activity(GO:0015026) |
1.0 | 2.9 | GO:0031404 | chloride ion binding(GO:0031404) |
1.0 | 7.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.9 | 8.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.9 | 7.4 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.9 | 2.8 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.9 | 13.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.9 | 3.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 6.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.9 | 6.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.9 | 0.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.9 | 3.6 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.9 | 8.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.9 | 23.3 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.9 | 3.6 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.9 | 17.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.9 | 2.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 13.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.8 | 4.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.8 | 4.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 14.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.8 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 4.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.8 | 1.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 3.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.8 | 3.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.8 | 3.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 7.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.8 | 1.5 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 4.6 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.8 | 2.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.7 | 6.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 15.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.7 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 4.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 6.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 7.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.7 | 6.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.7 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.8 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.7 | 3.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.7 | 22.1 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 1.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.7 | 2.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.7 | 6.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 3.4 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.7 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 2.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.7 | 6.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.7 | 10.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 2.7 | GO:0004950 | chemokine receptor activity(GO:0004950) |
0.7 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 14.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.7 | 3.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.7 | 10.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 2.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.6 | 2.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 1.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 2.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 3.1 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 10.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.6 | 6.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 8.6 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 2.4 | GO:0032896 | stearoyl-CoA 9-desaturase activity(GO:0004768) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.6 | 10.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.6 | 5.4 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.6 | 3.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.6 | 10.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.6 | 6.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 2.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 1.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.6 | 5.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 3.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 5.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 3.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 1.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.6 | 2.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 3.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 8.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 3.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 2.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 4.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 22.7 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 17.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.5 | 13.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.5 | 11.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 1.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 8.6 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 13.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.5 | 2.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 2.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.5 | 5.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 10.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 2.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 4.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 2.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 15.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.5 | 9.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 6.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.5 | 10.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 26.1 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.5 | 2.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 4.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 3.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 6.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 6.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 8.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 2.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 10.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 7.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.5 | 6.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.5 | 6.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 4.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 3.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 2.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 4.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 6.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 6.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 5.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 3.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.4 | 12.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.4 | 6.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.4 | 2.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.4 | 3.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 6.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 6.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 13.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 1.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 1.2 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
0.4 | 2.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 4.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 3.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 24.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 7.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 8.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.4 | 3.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.9 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.4 | 2.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.4 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 8.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 9.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 5.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 6.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.7 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.3 | 6.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 11.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 9.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 3.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.6 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.3 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 7.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 2.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 3.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 15.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 6.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 5.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 1.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 23.1 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.3 | 6.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 8.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 6.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 4.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 66.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 9.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.3 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 1.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.7 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 0.7 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 4.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 12.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 10.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 2.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 6.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 21.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 16.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 3.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 4.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.4 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.2 | 1.1 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 6.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 6.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 1.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 4.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 11.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 3.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 8.3 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.1 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 8.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 4.9 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 5.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 12.9 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.9 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 5.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.8 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 4.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 2.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 2.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 4.3 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 1.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 19.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 21.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 111.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.1 | 114.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.6 | 18.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.5 | 28.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.5 | 12.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.5 | 64.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.3 | 27.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 3.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 3.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.2 | 12.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 18.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 44.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.1 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.0 | 79.9 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 28.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.0 | 231.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.0 | 4.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.9 | 5.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.8 | 20.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 19.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 2.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 6.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.8 | 31.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 8.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 15.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.7 | 3.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 15.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 19.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 8.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 40.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 8.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 7.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 6.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 9.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 3.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 8.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 7.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 9.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 14.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 4.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 9.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 7.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 8.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 6.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 10.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 9.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 2.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 17.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 9.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 40.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 5.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 5.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 2.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 4.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 9.4 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 3.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 10.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 4.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 6.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 5.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 4.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 3.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 3.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 4.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 71.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
5.1 | 87.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
5.1 | 15.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
4.6 | 55.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
4.6 | 41.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.7 | 70.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
3.6 | 43.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.4 | 20.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.2 | 28.6 | REACTOME DEFENSINS | Genes involved in Defensins |
3.0 | 6.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
3.0 | 59.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.0 | 41.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.9 | 31.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.8 | 2.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
2.7 | 38.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.6 | 35.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
2.5 | 28.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
2.5 | 43.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.5 | 31.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.3 | 32.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.1 | 29.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.1 | 63.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.0 | 19.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.0 | 9.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.9 | 23.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.9 | 22.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.9 | 75.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
1.8 | 29.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.8 | 79.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.6 | 3.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.6 | 3.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.5 | 4.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.5 | 18.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.5 | 49.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.5 | 17.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.4 | 17.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.4 | 17.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.4 | 28.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.4 | 19.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.4 | 27.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.4 | 2.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.3 | 66.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.3 | 252.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.3 | 60.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 7.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.2 | 37.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.2 | 48.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.2 | 6.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.2 | 14.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.2 | 32.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.2 | 16.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.1 | 16.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.1 | 40.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.1 | 21.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.1 | 8.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.0 | 7.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.0 | 14.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 59.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.0 | 11.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 2.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.9 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.9 | 46.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.9 | 10.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 6.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.8 | 17.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 6.5 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 59.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 4.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.8 | 0.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.8 | 10.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 11.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.7 | 28.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.7 | 13.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 12.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.7 | 6.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.7 | 10.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 12.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 7.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 10.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.6 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 19.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 14.0 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.6 | 6.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 6.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 3.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.5 | 3.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 8.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 5.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 11.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 5.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 9.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 5.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 6.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 2.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 2.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 7.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 6.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 7.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 18.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 11.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 5.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 1.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 6.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 12.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 44.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 6.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 17.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 6.4 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.3 | 6.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 2.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 2.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 0.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 8.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 5.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 3.9 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.3 | 7.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 6.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 3.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 2.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.3 | 2.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 2.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 5.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 4.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 3.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 6.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 1.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 3.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 7.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 15.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 5.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 8.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.6 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |